Elekta (OTCMKTS:EKTAY) Shares Gap Down – What’s Next?

Elekta AB (OTCMKTS:EKTAY)’s share price gapped down before the market opened on Tuesday . The stock had previously closed at $5.24, but opened at $4.88. Elekta shares last traded at $4.88, with a volume of 5,426 shares.

Analysts Set New Price Targets

Separately, Zacks Research lowered shares of Elekta from a “hold” rating to a “strong sell” rating in a report on Tuesday, June 2nd. Two analysts have rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Elekta Stock Up 1.0%

The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.68 and a current ratio of 0.87. The firm has a fifty day simple moving average of $5.57 and a 200-day simple moving average of $5.95. The company has a market capitalization of $1.81 billion, a PE ratio of -30.69 and a beta of 1.01.

Elekta (OTCMKTS:EKTAY) last released its earnings results on Thursday, May 28th. The company reported $0.06 EPS for the quarter. Elekta had a positive return on equity of 11.11% and a negative net margin of 3.32%.The company had revenue of $521.00 million during the quarter. Equities research analysts anticipate that Elekta AB will post 0.43 EPS for the current fiscal year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.